Search results
Regeneron (NASDAQ:REGN): Is This Stock-Split Contender a Strong Buy?
TipRanks via Yahoo Finance· 1 day agoRegeneron (NASDAQ:REGN) stock has more than tripled in value in the past five years, with the price...
Nvidia's One-Day Loss Exceeds The Value Of 85% Of The S&P 500
Investor's Business Daily· 10 hours agoThink you had a bad day? It's nothing compared to the drop Thursday by S&P 500 stock Nvidia. Shares...
JPMorgan Chase & Co. Raises Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target to $1,150.00
ETF DAILY NEWS· 4 days agoRegeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target raised by JPMorgan Chase & Co. from $1,050.00 to $1,150.00 in a report issued ...
Regeneron director Brown sells shares worth over $1.5 million By Investing.com
Investing.com· 4 days ago:REGN) Director Michael S. Brown has completed a significant transaction involving the company's ...
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by Integrated Advisors Network LLC
ETF DAILY NEWS· 2 days ago(NASDAQ:REGN – Free Report) by 6.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 257 shares of the biopharmaceutical company ...
Teachers Retirement System of The State of Kentucky Sells 1,245 Shares of Regeneron Pharmaceuticals,...
ETF DAILY NEWS· 5 days agoThe firm owned 17,346 shares of the biopharmaceutical company’s stock after selling 1,245 shares during the quarter. Teachers Retirement System of The State of Kentucky’s ...
Equities Research Analysts’ Price Target Changes for June 17th (ACN, AMAT, AMH, ARM, ASML, AVB,...
ETF DAILY NEWS· 4 days agoEquities Research Analysts’ price target changes for Monday, June 17th: Accenture (NYSE:ACN) had its...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 7 hours agoUnited Therapeutics stock also lands on the Tech Leaders list. Vertex, One Of The Biggest...
Splits Coming? 13 Stocks Still Cost A Ridiculous $1,000 Or More
Investor's Business Daily· 3 days agoS&P 500 Stocks All trade for 1,000 or more Company Ticker Stock price YTD % ch. Sector Berkshire...
...Pomerantz Law Firm Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals, Inc....
Benzinga· 6 days agoNEW YORK, June 15, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Regeneron Pharmaceuticals, Inc. ("Regeneron" or the "Company") (NASDAQ:REGN). Such investors are